For most of a generation now the pharmaceutical industry has been on a journey from manual, paper-intensive methods toward more automated, electronic ways to make a product. It has been a cautious journey; the FDA does not like ambiguity and uncertainty. But we may soon see a cultural and technological shift that will not only replace manual methods with electronic ones, but enable new ways to operate an enterprise.
If those new tools and methods are not built on a stable, simple, absolutely reliable platform we may spend more energy worrying about the tools than the problems they should fix.
In this webinar we will discuss:
- The case for digitization: moving to electronic systems; electronic procedures and new industry standards
- Industry changes: process analytics, single use production units, continuous production, contract processing
- Considerations for IIoT: validation, data analysis, data security, and edge technology
- The path to a digitized enterprise: fault tolerance and operational simplicity; predictive, preventive and proactive support; future vision
Moderator: Karen Langhauser, Chief Content Director, Pharmaceutical Manufacturing
